Home › Atherosclerosis › Nevada
Atherosclerosis clinical trials in Nevada
5 studies for Atherosclerosis are looking for participants at sites in Nevada.
Cities in Nevada
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Vector Clinical Trials, Las Vegas
RecruitingPhase 3
Ages 45 to 80 · All sexes · Updated Nov 4, 2026 · NCT07613294A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Desert Clinical Research, LLC, Henderson
- Clinical Research of South Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DaVita Clinical Research - Henderson, Henderson
- Kidney Specialists of Southern Nevada, Las Vegas
- Sierra Nevada Specialty Care, Reno
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Las Vegas
- Research Site, Las Vegas
- Research Site, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.